| name | pdm-delivery-timing |
| description | Recommends early delivery based on individualized risk assessment rather than expectant management for pregnant patients with preexisting diabetes mellitus (PDM). Consider when evaluating delivery timing in the presence of diabetes‑related complications, suboptimal glycemia, abnormal fetal growth, or maternal comorbidities that may increase perinatal risk beyond 38 weeks gestation. |
Early Delivery Based on Risk Assessment in Preexisting Diabetes
STEP 1 — Gather Information
Collect maternal diabetes type and duration, history of complications (nephropathy, retinopathy, cardiovascular disease), glycemic control (HbA1c, time in range, CGM metrics), obstetric history (prior stillbirth, preterm birth), fetal assessment (ultrasound estimated fetal weight, amniotic fluid index, Doppler), maternal comorbidities (hypertension, obesity, thyroid disease), and current gestational age.
STEP 2 — Rule In / Rule Out
Is there any high‑risk feature present (e.g., prior perinatal loss, hypertensive disorder, nephropathy, fetal growth abnormality, persistent hyperglycemia despite therapy)? If yes → proceed to risk stratification; if no → continue expectant management with weekly review.
STEP 3 — Classify or Stratify
Stratify risk into high (any major complication or poor glycemia) versus low (no complications, glycemia within target, normal fetal growth). High risk suggests consideration of delivery between 37+0 and 38+6 weeks; low risk permits expectant management up to 39+0 weeks.
STEP 4 — Decide
For high‑risk patients, schedule delivery at the earliest gestational age deemed safe based on individual risk factors (typically 37–38 weeks) after confirming fetal lung maturity if <39 weeks; for low‑risk patients, continue expectant management with weekly antenatal testing and reassess at each visit.
Clinical Guardrails / Mimics / Pitfalls
Do not deliver before 37 weeks without clear obstetric indication; avoid expectant management beyond 38 weeks in the presence of any high‑risk factor; do not rely solely on gestational age without risk assessment; do not use a single 24‑hour CGM target <140 mg/dL as a surrogate for comprehensive risk evaluation; and remember that even ideal glycemic control does not eliminate the need for risk‑based timing.
Concrete Clinical Example
A 34‑year‑old with type 2 diabetes for 10 years, HbA1c 7.2%, mild diabetic nephropathy, and ultrasound showing fetal abdominal circumference at the 90th percentile is classified as high risk; delivery is planned at 38 weeks after corticosteroid administration for fetal lung maturity.
Source: Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline, Endocrine Society/European Society of Endocrinology, 2025, https://doi.org/10.1210/clinem/dgaf288
